NO923271L - expression - Google Patents
expressionInfo
- Publication number
- NO923271L NO923271L NO92923271A NO923271A NO923271L NO 923271 L NO923271 L NO 923271L NO 92923271 A NO92923271 A NO 92923271A NO 923271 A NO923271 A NO 923271A NO 923271 L NO923271 L NO 923271L
- Authority
- NO
- Norway
- Prior art keywords
- expression systems
- desired polypeptide
- cdna
- vector
- expression
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 239000013598 vector Substances 0.000 abstract 3
- 239000002299 complementary DNA Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 210000000267 erythroid cell Anatomy 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Ekspresjonssystemer som omfatter en pattedyr-vert slik. som erytroide celler, transformert med en vektor som omfatter en promotor, en DNA-sekvens som koder for et ønsket polypeptid og et dominant kontrollområde. Vektorene og fremgangs-måtene for fremstilling av polypeptidene ved bruk av ekspresjonssystemene er også beskrevet. I en foretrukket utførelsesform inneholder vektoren cDNA for det ønskede poly-peptidet og en sekvens som er i stand til å stabilisere mRNA laget fra cDNA. Disse ekspresjonssystemene er spesielt effektive og i stand til å utskille det ønskede polypeptidet.Expression systems comprising such a mammalian host. as erythroid cells, transformed with a vector comprising a promoter, a DNA sequence encoding a desired polypeptide and a dominant control region. The vectors and methods of making the polypeptides using the expression systems are also described. In a preferred embodiment, the vector contains cDNA for the desired polypeptide and a sequence capable of stabilizing mRNA made from cDNA. These expression systems are particularly effective and capable of secreting the desired polypeptide.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909027917A GB9027917D0 (en) | 1990-12-21 | 1990-12-21 | Expression systems |
| PCT/GB1991/002274 WO1992011380A1 (en) | 1990-12-21 | 1991-12-19 | Expression systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO923271D0 NO923271D0 (en) | 1992-08-20 |
| NO923271L true NO923271L (en) | 1992-10-16 |
Family
ID=26298168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92923271A NO923271L (en) | 1990-12-21 | 1992-08-20 | expression |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO923271L (en) |
-
1992
- 1992-08-20 NO NO92923271A patent/NO923271L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO923271D0 (en) | 1992-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2251622B (en) | Expression systems | |
| EP0728214A4 (en) | Stable cell lines capable of expressing the adeno-associated virus replication gene | |
| GB9216151D0 (en) | Containment of plant germplasm | |
| WO1994003616A3 (en) | Cloning and/or sequencing vector | |
| HU9400960D0 (en) | Synthetic dna sequence having enhanced insecticidal activity in maize | |
| DK547185D0 (en) | VECTORS FOR EXPRESSION OF HIRUDIN, TRANSFORMED CELLS AND PROCEDURES FOR THE PREPARATION OF HIRUDIN | |
| DK470184A (en) | CDNA CLONES CODING FOR POLYPEPTIDES THAT EXPRESSIVE GROWTH FACTOR ACTIVITY WITH REGARD TO MANY DIFFERENT CELLS AND / OR MAST CELLS | |
| EP0196864A3 (en) | Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences | |
| EP0538404A4 (en) | Fibroblast growth factor receptors | |
| IL84229A0 (en) | Human apolipoprotein ai and variant form thereof expressed in escherichia coli | |
| CA2309600A1 (en) | Low-temperature inducible expression vector | |
| DK1268823T3 (en) | Methods and cells for expression of recombinant protein products | |
| GB2253852B (en) | Vector for expression of heterologous polypeptide comprising inducible selection system | |
| NO923271L (en) | expression | |
| NO971378L (en) | Cytokine designated LERK-6 | |
| NO995959L (en) | DNA sequence, vector, transformed eukaryotic or prokaryotic host cells, processes for producing a protein, polypeptide, antibody, isolation and identification method, pharmaceutical composition and screening method. | |
| ES8800353A1 (en) | MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR). | |
| DE3479816D1 (en) | A promotor and use thereof | |
| NO974713L (en) | Genes encoding lymphocyte interferon regulatory factor (LSIRF) polypeptides | |
| ZA916106B (en) | Cloning and expression of a rhoptry-associated protein of p.falciparum | |
| NO883611L (en) | EXPRESSION PLASMIDS CONTAINING DEO PROMOTERS, AND BACTERIAL HOSTS CONTAINING THESE PLASMIDS. | |
| EP0160190A3 (en) | Genetic expression of somatostatin as hybrid polypeptide | |
| NO944126L (en) | Improved production of reproductive hormones | |
| DK200200302A (en) | Recombinant polypeptides comprising the amino acid sequence of mature tissue factor inhibitor (TFI), polypeptide fragments thereof, expression vectors encoding them, host cells transformed therewith, and method for producing a ........ |